← FDA Drug Approvals (Drugs@FDA)

MVASI

BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2017-09-14

Drug application

FDA Application #

BLA761028

Application type

Biologics License Application

Brand name

MVASI

Generic name

BEVACIZUMAB-AWWB

Active ingredients

BEVACIZUMAB-AWWB

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

AMGEN INC

Manufacturer

Amgen, Inc

First approval

2017-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown